New Zealand markets closed

Rivian Automotive, Inc. (RIVN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
11.42+0.43 (+3.93%)
As of 11:54AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close10.99
Open10.90
Bid9.54 x 100
Ask11.40 x 400
Day's range10.88 - 11.43
52-week range10.05 - 28.06
Volume21,221,135
Avg. volume42,989,181
Market cap11.164B
Beta (5Y monthly)1.89
PE ratio (TTM)N/A
EPS (TTM)-5.74
Earnings date07 May 2024 - 13 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est18.60
  • Zacks

    Rivian Automotive (RIVN) Declines More Than Market: Some Information for Investors

    In the most recent trading session, Rivian Automotive (RIVN) closed at $10.52, indicating a -1.22% shift from the previous trading day.

  • Yahoo Finance Video

    Rivian is 'well positioned' for future growth: Autoblog

    Mizuho analysts downgraded EV makers Rivian (RIVN), Tesla (TSLA), and Nio Inc. (NIO) to Neutral ratings on slowing EV demand, even in Chinese markets. Autoblog Editor-In-Chief Greg Migliore weighs in on the rising popularity of Korean automakers and where Rivian's vehicles have room to run in this auto market. "Rivian is well positioned for growth a few years down the road. I think what is tricky for them is they started out with the R1S and the R1T... which are pretty expensive," Migliore says. "They're definitely luxury items. They bring that lifestyle sort of approach to well-heeled consumers who want to have a discussion piece when they pull up wherever they might be going." For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Luke Carberry Mogan.

  • Yahoo Finance Video

    Tesla, Lucid, Novo Nordisk: Trending tickers

    EV makers Tesla (TSLA), Rivian (RIVN), and NIO (NIO) have all received a downgrade from Mizuho Securities to Neutral citing near-term demand and challenges with liquidity going into next year. Shares of Lucid (LCID) are jumping Monday morning after the EV maker announced a $1 billion investment from its majority stockholder, Ayar Third Investment Company, to buy newly created convertible preferred stocks.  Novo Nordisk (NVO) is set to acquire Cardior Pharmaceuticals, a company that develops RNA-based therapeutics for heart disease. The deal includes a heart failure treatment in phase two of clinical development Yahoo Finance Anchors Madison Mills and Seana Smith break down the latest developments for these companies. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.Editor's note: This article was written by Nicholas Jacobino